MTOR and neoplasm: It has been shown that conditioning of T cells with MDSCs leads to reduced mTOR activity in T cells as well as increased adoptive T cell-based immunotherapy (ACT) anti-tumor efficacy, suggesting the critical role of MDSCs in mTOR-mediated CD8+ T cells differentiation into effector populations (152).